Search

everythinglearnresearchcommunity

for

Search:↓

Double-spin PRP is more effective for treating female hair loss than single-spin PRP.

PRP shows promise for short-term hair growth, especially in young men.

Trichoscopy helps tell different hair loss types apart using specific scalp and hair patterns.

Low-dose oral minoxidil is effective and safe for treating androgenetic alopecia.

Severe male pattern hair loss is linked to lower hair density in the back of the head.

Combining fractional CO2 laser and PRP is very effective for treating female hair loss.

Botulinum toxin A has limited effectiveness for 3 months in treating female pattern hair loss and may reduce scalp oiliness.

Female pattern hair loss greatly affects women's quality of life, causing mild depression and anxiety, and increases medical expenses.

Combining minoxidil with dutasteride and microneedling is more effective for female pattern hair loss than just dutasteride and microneedling.

Americans see hair transplants as valuable for treating hair loss and want them to be more affordable and tailored to each gender.

Women with Female Pattern Hair Loss may experience more stress, anxiety, and depression, and have lower levels of BDNF, which could predict the psychological impact.

Smoking increases the risk of hair loss, especially male pattern baldness.

Men with a family history of hair loss on their mother's side are more likely to have female pattern hair loss.

Combining PRP with other treatments can improve hair loss outcomes.

Some Greek melanoma patients have gene mutations linked to increased cancer risk, a new color feature helps diagnose melanoma, the incidence of a skin condition in the Netherlands is rare, and a gene possibly affects male-pattern baldness.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

Female pattern hair loss in Western India is common and often linked to metabolic syndrome.

Trichoscopy is essential for early detection and monitoring of female-pattern hair loss.

Artificial intelligence can accurately predict hair growth and treatment results in female pattern hair loss patients, with age of onset and duration being key factors.

Female pattern hair loss does not significantly affect sexual dysfunction.

PRP and LLLT can improve hair growth in AGA, but more research needed.

Stem cells preservation in AGA could be a potential therapy, but more cases needed.

AGA patients have higher rates of metabolic syndrome and carotid atheromatosis, suggesting early screening and prevention is important.

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

AGA linked to worse COVID-19 outcomes in men.

Certain scalp patterns can indicate the severity and activity of hair loss in Turkish alopecia patients.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.